Related Experiment Video
Updated: Sep 7, 2025

05:51
Digital-Droplet PCR to Detect Indels Mutations in Genetically Modified Anopheline Mosquito Populations
Published on: June 28, 2021
3.6K
The development of an indel panel for microchimerism detection.
Sofie D H Olsen1, Astrid M Kolte2, Nina Bang1
1Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Experimental and Molecular Pathology
|June 19, 2022
Summary
A new indel assay efficiently detects fetal microchimerism in maternal samples, regardless of sex. This method offers a sex-independent approach for microchimerism analysis, removing bias in health and disease research.
Area of Science:
- Reproductive immunology
- Molecular diagnostics
- Genetics
Background:
- Microchimerism, the exchange of cells between mother and fetus, plays a role in various physiological and pathological conditions.
- Existing methods for microchimerism detection often rely on sex-mismatch or HLA genotyping, limiting their applicability.
Purpose of the Study:
- To develop a simple, sex-independent assay for microchimerism detection without the need for HLA genotyping.
- To evaluate the efficacy of a novel insertion/deletion (indel) based assay compared to a Y-chromosome marker assay.
Main Methods:
- A multiplex PCR assay detecting insertion/deletion (indel) polymorphisms was developed.
- Fragment analysis by capillary electrophoresis and probe-based qPCR were employed for detection.
- 192 samples from 97 female patients with recurrent pregnancy loss were analyzed using the indel assay and a DYS14 (Y-chromosome) assay.
Main Results:
- The indel method detected microchimerism in 32% of samples, while the DYS14 assay detected it in 29%.
- An overall agreement of 64% was observed between the two methods.
- No statistically significant differences in microchimerism prevalence were found between the methods at different sampling times.
Conclusions:
- The indel assay efficiently detects fetal microchimerism in maternal samples.
- This method allows for the detection of both female and male microchimerism without sex bias or HLA genotyping.
- The indel assay has the potential for routine implementation in clinical diagnostics and research.

